Related Experiment Video
Updated: Jun 25, 2026
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Innate immunity and primary biliary cirrhosis
Carlo Selmi1, Ana Lleo, Simone Pasini
1Department of Internal Medicine, IRCCS Istituto Clinico Humanitas, University of Milan, and Division of Internal Medicine and Liver Unit, San Paolo Hospital School of Medicine, Milan, Italy.
Current Molecular Medicine
|February 10, 2009
Summary
Primary biliary cirrhosis (PBC) research reveals innate immunity
Area of Science:
- Immunology
- Hepatology
- Autoimmunity
Background:
- Understanding of primary biliary cirrhosis (PBC) molecular basis has grown rapidly.
- Research initiated with cloning and sequencing of immunodominant mitochondrial autoantigen.
- Focus on effector mechanisms and intrahepatic bile duct pathology.
Purpose of the Study:
- Investigate the role of innate immunity in PBC initiation and perpetuation.
- Explore how innate immune responses exacerbate autoimmune injury.
- Identify potential therapeutic targets within innate immune pathways.
Main Methods:
- Utilized recombinant cloned mitochondrial autoantigen as a research tool.
- Developed experimental models of PBC based on available data.
- Analyzed experimental data suggesting changes in innate immunity.
Main Results:
- Experimental data indicate innate immunity changes are critical in PBC.
- Enhanced responses of monocytes and memory B cells observed.
- Multiple initiation mechanisms for PBC identified, leading to loss of tolerance.
Conclusions:
- Innate immune responses significantly exacerbate PBC pathology once adaptive response develops.
- Future PBC therapies may depend on understanding and modulating innate immune cytotoxicity.
- Further research into innate immunity is crucial for understanding PBC etiology.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:21Introduction to Innate and Adaptive Immunity
The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...